CoChat

Possible contribution of IGF-1 to depressive disorder

Open access
Szczęsny, Ewa, Ślusarczyk, Joanna, Głombik, Katarzyna, Budziszewska, Bogusława, Kubera, Marta, Lasoń, Władysław, Basta-Kaim, Agnieszka · 2013 · Pharmacological Reports

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Abstract

Depression is an illness of unknown origin and involves the dysregulation of many physiological processes disturbed in this disease. It has been postulated that the pathomechanism of depression is complex, and apart from changes in neurotransmitters, a dysregulation of the immune and endocrine systems also plays an important role in the development of this disorder. Recent studies indicate that an impairment of synaptic plasticity in specific areas of the central nervous system (CNS), particularly the hippocampus, may be an important factor in the pathogenesis of depression. The abnormal neural plasticity may be related to alterations in the levels of neurotrophic factors. On this basis, a theory connecting the occurrence of depression with disturbances in neurotrophic factors has gained great attention. This review summarizes data suggesting a role for the neurotrophic factors - especially insulin-like-growth factor-1 (IGF-1) - as possible targets for therapy in depression in the context of depressive behavior modulation, anti-inflammatory action and neuroprotection.

Overview

Integrity signals

Registry

Crossref · 10.1016/s1734-1140(13)71523-8

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 43 references

Research works printed but not linked: 2

  1. Park, 2011, Insulin-like growth factor-I pepides act centrally to decrease depression-like behavior of mice treated intraperitoneally with lipopolisaccharide, J Neuroinflamm, 8, 1
  2. Wysokiński, 2008, Neurotrophins – actual knowledge (Polish), Post Psychiat Neurol, 17, 385

Cited by

See all 70

Metadata

Authors
Szczęsny, E., Ślusarczyk, J., Głombik, K., Budziszewska, B., Kubera, M., Lasoń, W., & Basta-Kaim, A.
Affiliations
Maj Institute of Pharmacology (PL)
Venue
Pharmacological Reports
Published
2013-11
Volume
65
Issue
6
Pages
1622-1631
ISSN
1734-1140 (ISSN-L)
OpenAlex
W1968946286
Cited by
68
References
42
Citations by year
2026: 4 · 2025: 5 · 2024: 7 · 2023: 4 · 2022: 2 · 2021: 10 · 2020: 6 · 2019: 5 · 2018: 5 · 2017: 5 · 2016: 6 · 2015: 7 · 2014: 1 · 2013: 1
FWCI
0.63
Type
journal article
Language
en
Open access
Licence
  • cc-by-nc-nd
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Pharmacological Reports (publishedVersion)
  • PubMed (publishedVersion)
  • Jagiellonian University Repository (Jagiellonian University) (submittedVersion, cc-by-nc-nd)
Funders
  • Depression-Mechanisms-Therapy (POIG. 01.01.02-12-004/09-00)
  • European Regional Development Fund
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
Keywords
insulin-like growth factor I, depression, neurotrophic factors, synaptic plasticity, hippocampus, neuroprotection, anti-inflammatory activity, immune dysregulation, endocrine dysfunction, antidepressant targets, depression-like behavior
MeSH terms
Animals, Antidepressive Agents, Central Nervous System, Depressive Disorder, Humans, Insulin-Like Growth Factor I, Nerve Growth Factors, Neuronal Plasticity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Possible contribution of IGF-1 to depressive disorder. https://app.cochat.ai/papers/10.1016/s1734-1140(13)71523-8
The paper
Szczęsny, E., Ślusarczyk, J., Głombik, K., Budziszewska, B., Kubera, M., Lasoń, W., & Basta-Kaim, A. (2013). Possible contribution of IGF-1 to depressive disorder. Pharmacological Reports. https://doi.org/10.1016/s1734-1140(13)71523-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.